Abstract: This application provides an electrode sheet and an electrochemical device. The electrode sheet includes a current collector and a functional coating located on at least one surface of the current collector. The functional coating includes a first coating, a second coating and an active material layer that are sequentially stacked on a surface of the current collector. The first coating includes a conductive agent, a binder and a first functional filler, and the second coating includes a conductive agent, a binder and a second functional filler. A mass ratio of the binder in the first coating to the first coating is a1, a mass ratio of the binder in the second coating to the second coating is a2, and a mass ratio of the binder in the active material layer to the active material layer is a3, and a1>a2>a3.

Abstract: The present invention relates to the technical field of pharmaceuticals and specifically describes an application of a 5-hydroxytryptamine receptor 1A in preparing a drug for portal hypertension. The present invention achieved a significant decrease in portal venous pressure in model rats with cirrhotic portal hypertension by means of an HTR1A inhibitor WAY100635 administered at 1 mg/kg/day by intraperitoneal injection or alverine administered at 15 mg/kg/day by oral gavage. A 5-hydroxytryptamine receptor 1A antagonist can be used to prepare an experimental drug for the treatment of cirrhotic portal hypertension. Furthermore, the 5-hydroxytryptamine receptor 1A antagonist can also be used to prepare drugs for symptoms of portal hypertension syndrome, such as esophageal and fundal varices, rupture and bleeding, ascites, or hepatic encephalopathy.

Abstract: An automatic analysis device, an analysis method, and an analysis system are provided. The automatic analysis device comprises an incubation unit.

Abstract: An automatic analysis device, an analysis method, and an analysis system are provided. The automatic analysis device comprises an incubation unit.

Abstract: A component analysis method of an automatic analysis device is provided. The automatic analysis device includes an incubation unit that holds at least one reaction container and a plurality of executing stations set around the incubation unit to correspondingly perform a plurality of analysis operations to the reaction container.

Abstract: Provided are methods of targeted expression by the cartilage-derived retinoic acid-sensitive protein (CD-RAP) promoter. It is also directed to nucleic acid constructs and vectors useful for expression of nucleic acid sequences targeted to cartilage during development or in adult cartilage tissue, or for their expression in specific tumor cells such as chondrosarcomas and mammary tumor cells. The invention also relates to transgenic animals altered to contain the CD-RAP promoter transgene.